Score Overview
Explore the 2021 public Archive ranking →
Where LeMaitre Vascular Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- LMAT
2017: 15.0% · 2021: 7.2% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-23 | $ 84.45 | — |
1 Year2025-10-23 | $ 88.12 | -4.16% |
5 Years2021-10-22 | $ 51.59 | 63.69% |
10 Years2016-10-21 | $ 18.06 | 367.73% |
20 Years2006-10-23 | $ 5.36 | 15x |
All Time2006-10-19 | $ 5.16 | 16x |
| Period | Last Price2026-10-23 | 1 Year2025-10-23 | 5 Years2021-10-22 | 10 Years2016-10-21 | 20 Years2006-10-23 | All Time2006-10-19 |
|---|---|---|---|---|---|---|
| Price | $ 84.45 | $ 88.12 | $ 51.59 | $ 18.06 | $ 5.36 | $ 5.16 |
| Return | — | -4.16% | 63.69% | 367.73% | 15x | 16x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 262M | $ 65M | $ 376M |
| 2025 | $ 249M | $ 57M | $ 359M |
| 2024 | $ 219M | $ 44M | $ 299M |
| 2023 | $ 193M | $ 30M | $ 105M |
| 2022 | $ 161M | $ 20M | $ 82M |
| 2021 | $ 154M | $ 26M | $ 69M |
| 2020 | $ 129M | $ 21M | $ 26M |
| 2019 | $ 117M | $ 17M | $ 32M |
| 2018 | $ 105M | $ 22M | $ 47M |
| 2017 | $ 100M | $ 17M | $ 41M |
| 2016 | $ 89M | $ 10M | $ 24M |
| 2015 | $ 78M | $ 7M | $ 27M |
| 2014 | $ 71M | $ 3M | $ 18M |
| 2013 | $ 64M | $ 3M | $ 14M |
| 2012 | $ 56M | $ 2M | $ 16M |
| 2011 | $ 57M | $ 2M | $ 20M |
| 2010 | $ 56M | $ 6M | $ 22M |
| 2009 | $ 50M | $ 1M | $ 24M |
| 2008 | $ 48M | -$ 3M | $ 21M |
| 2007 | $ 41M | -$ 2M | $ 22M |
| IPO2006 | $ 34M | -$ 1M | $ 30M |
LeMaitre Vascular Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 78M to $ 249M and net income grew from $ 7M to $ 57M. Revenue increased in every one of those 10 years; net income in 8.
Across LeMaitre Vascular Inc's full reported history, from 2006 to 2025, revenue grew from $ 34M to $ 249M and net income went from -$ 1M to $ 57M. Revenue increased in 95% of the years measured; net income in 75%.
LeMaitre Vascular Inc currently holds a 20-year HDB Score of 8.3 out of 10. How the HDB Score is calculated.
Membership
Continue LMAT’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,112 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Universal Health Services IncUHS· revenue grew in 95% of years
Mettler-Toledo International IncMTD· revenue grew in 85% of years
UnitedHealth Group IncorporatedUNH· revenue grew in 100% of years
UFP Technologies IncUFPT· revenue grew in 80% of years
West Pharmaceutical Services IncWST· revenue grew in 90% of years
